Take part in research

Take part in research

Research into Parkinson’s continues to be on the rise in Australia and internationally.

Taking part in a research project may result in a better understanding of, or better treatment or a potential cure for Parkinson’s. In some cases, research projects may provide access to new interventions before they are widely available.

Below are current research projects looking for participants

Investigating the usage of allied health services in people with Parkinson’s disease
following deep brain stimulation to the subthalamic nucleus.

Overview of study

Australian Catholic University is conducting an online survey study to investigate to what extent people with Parkinson’s disease following deep brain stimulation to the subthalamic nucleus are accessing allied health services.

A secondary aim is to identify the potential facilitators to aid accessibility to these services. Your participation will help to identify what services you believe should be prioritised for your community to best address your symptoms and how to optimally deliver these services to improve overall quality of life.

This online survey will take approximately 20 minutes to complete, and this study has been approved by the ACU Human and Research Ethics Committee (2025-4513SAP)

Participant Criteria:

  • Are aged over 18 years old
  • Received Deep Brain Stimulation to the subthalamic nucleus
  • Being greater than 1 year post deep brain stimulation surgery

How to Sign Up and Contact Information

For more information or to participate in this survey, click the link below:
https://acu.qualtrics.com/jfe/form/SV_20ozqX29dW3LCfk

CURIOUS Study

Overview of Study

This study is being run by researchers at The University of Melbourne (Vascular Bionics Laboratory, led by Professor Nick Opie and team). They want to hear from people living with movement disorders and those who care for them.

Deep brain stimulation (DBS) is a treatment for movement disorders such as Parkinson’s disease, dystonia and essential tremor.

It uses thin wires placed in the brain, connected to a small device (like a pacemaker) that sends tiny electrical signals to help control symptoms.

The research team wants to understand:

  • What matters most to people when thinking about DBS
  • What questions or worries they have
  • How DBS and similar treatments affect them and their families

Your views will help guide the design of future DBS treatments, including less invasive options.

Participant Criteria 

  • 18 years or older, and
  • Have a movement disorder(e.g. Parkinson’s disease, dystonia, essential tremor), and one of these applies:
  • You are considering DBS, or
  • You have DBS now, or
  • You had DBS in the past
  • You need to be able to give informed consent and take part in an interview by phone, online, or in person.

What Participation Entails

Take part in one interview (about 30-60 minutes) This may be:

  • By telephone,
  • Online (video call), or
  • Face-to-face, either one-on-one or in a small group (up to 5 people)

Researchers will ask about:

  • Your experience of movement disorders
  • Your thoughts and feelings about DBS and similar treatments
  • What is important to you in daily life

With your permission, the interview will be audio recorded. The recording will be written out, and your name will not be used. Taking part will not affect your medical care.

To thank you for your time you will be given a supermarket voucher by the researcher. For in person attendance reasonable travel costs will be re-imbursed.

How to Sign Up

Please contact Christin Mathew, Vascular Bionics Laboratory, The University of Melbourne.
Phone: 0480 556 824

Research & Clinical Trial Updates

Research into Parkinson’s is happening every day across Australia and around the world. From clinical trials and exercise studies to emerging therapies and technology, these updates help connect the Parkinson’s community with the latest developments, opportunities and conversations in research.

Whether you’re interested in participating in research, learning about new studies or hearing directly from researchers and clinicians, this section will feature updates, webinars and opportunities relevant to the Parkinson’s community.

Latest Webinars & Updates

The Movement Disorder Society of Australia and New Zealand (MDSANZ) Clinical Trials Network hosts webinars featuring researchers, clinicians and experts discussing current Parkinson’s and movement disorder research, emerging treatments and clinical trials.

October 2025 webinar: The Future of movement disorder research

Speakers took viewers behind the scenes of current and upcoming clinical trials, shared new developments in the field, and highlighted research opportunities.

Speakers and topics

  • Alex Lehn: The MDSANZ Clinical Trials Network: updates on current and upcoming clinical trials
  • Niamh Hennessy: TarGAITed Stimulation Trial: stepping towards a non-invasive treatment for Parkinson’s disease walking impairments
  • Lucy Vivash: Clinical trials for Progressive Supranuclear Palsy
  • Aishwarya Mary Johnson: Hitting Parkinson’s where it hurts: a two-pronged attack
  • Richard Gordon: Understanding and targeting the gut microbiome in Parkinson’s disease
Watch the webinar



April 2026 Webinar: Trials, discoveries and the road ahead

Speakers explored the breadth of what the MDSANZ Clinical Trials Network and its partners are working on right now: from the genetics and immune signals that may shape who develops Parkinson’s, to the role of the gut microbiome, cognition, metabolism, and movement itself. We also previewed several new trials opening in our region, including studies in Progressive Supranuclear Palsy.

Speakers and topics

  • Alex Lehn: The MDSANZ Clinical Trials Network: who we are, current and upcoming trials across the region
  • Peter Nestor: Cognitive abilities in Parkinson’s disease
  • Victor Flores Ocampo: Can Parkinson’s be inherited? What genetics can tell us
  • Kunal Bhatt: Listening to the immune system: early clues in Parkinson’s disease
  • Matthew Phillips: Ketogenic metabolic therapy in Parkinson’s and Huntington’s
  • Divya Onkar Mondhe: The microbial mystery of Parkinson’s disease
  • Nadeeka Dissanayaka: Improving identification of cognitive impairment in Parkinson’s disease: the PDCogniCare program
  • Graham Kerr: Connecting brain and muscles for improved balance and gait
Watch the webinar